title
stringlengths
1
1.19k
keywords
stringlengths
0
668
concept
stringlengths
0
909
paragraph
stringlengths
0
61.8k
PMID
stringlengths
10
11
Study procedures
ICH, diabetes
DIABETES
The ADREM study (Adjustment of insulin Degludec to Reduce post-Exercise (nocturnal) hypoglycaeMia in people with diabetes) was an open-label, randomised controlled, three-way crossover study, conducted in accordance with the principles of the Declaration of Helsinki, the Medical Research Involving Human Subjects Act an...
PMC9988601
Study participants
hypoglycaemia
TYPE 1 DIABETES, EVENT, HYPOGLYCAEMIA
Adults aged 18–60 years were eligible for participation when they had been diagnosed with type 1 diabetes for at least 2 years, had been treated with a basal-bolus multi-dose insulin regimen for at least 1 year and were at increased risk of hypoglycaemia. The latter was defined as a history of at least one severe hypog...
PMC9988601
Screening visit
A schematic overview of the study design is shown in Fig. Overview of the study. Ex, exercise day; Scr, screening visit
PMC9988601
Exercise days
Each participant engaged in 3 exercise days and was randomly assigned by the investigator to an order of the three post-exercise degludec treatment regimens, i.e. no adjustment of insulin degludec (CON), a 40% dose reduction of degludec (D40) and 8 h postponement with a 20% dose reduction of degludec (D20-P). For D40, ...
PMC9988601
Study outcomes
EVENTS, EVENT
The primary outcome was the time below range (i.e. glucose <3.9 mmol/l) in the night (00:00–05:59 hours) following the exercise test. Secondary outcomes included times above range (i.e. glucose >10.0 mmol/l) and in range (i.e. glucose ≥3.9 mmol/l and ≤10.0 mmol/l), mean glucose concentration, number of hypoglycaemic an...
PMC9988601
Measurements
Plasma insulin was measured using an in-house radioimmunoassay, using an in-house-generated guinea pig anti-human insulin antibody and
PMC9988601
Statistical analyses
The sample size estimation was based on the two treatments for which the smallest difference was expected (D40 and CON). Given this was a crossover trial, it was expected that the other comparisons (with D20-P) would have sufficient power. No ɑ corrections were made to account for the multiple comparisons. Furthermore,...
PMC9988601
Results
SD
HYPOGLYCAEMIA
A total of 19 participants were screened, 18 of whom were included. One participant was withdrawn after screening because of personal reasons unrelated to the study. All 18 included participants completed the study. Their baseline characteristics are shown in Table Baseline characteristicsData are presented as number (...
PMC9988601
Exercise tests
ST-segment depression
The three 45 min exercise tests were performed consistently across all treatment groups regarding heart rate (CON 144 ± 3, D40 145 ± 3, D20-P 144 ± 3 beats per minute). All participants cycled at 70% of their heart rate reserve, except for one participant, who cycled all three tests at 57% heart rate reserve because of...
PMC9988601
Study outcomes
PMC9988601
Time below range and hypoglycaemic events
Time below range in the night after the exercise test was generally low and occurrence did not differ significantly between the treatment regimens (three participants in CON, one in D40, three in D20-P). The day after the exercise test, time below range was greater for CON compared with D40 (18 [0–55] vs 0 [0–23] min,
PMC9988601
Mean glucose concentration
No differences in mean glucose concentration were found between the treatment regimens the night after the exercise test (Fig. Time course of the mean glucose concentration over the first (
PMC9988601
Time above range
No differences in time above range were found between the treatment regimens the night after the exercise test. The day after the exercise test, D20-P led to significantly more time above range (584 ± 81 min) compared with CON (364 ± 66 min, Percentage of time spent above range, in range and below range the first night...
PMC9988601
Time in range
The night following the exercise test, D20-P was associated with less time in range compared with D40 (229 ± 30 vs 287 ± 26 min,
PMC9988601
Sensitivity analyses
Repeating the analyses according to the actual sleep times of the participants did not materially change the results, except that the night after the exercise test, the mean glucose concentration was higher for D20-P compared with CON (9.8 ± 0.8 vs 8.5 ± 0.5 mmol/l,
PMC9988601
Fasting ketones
Fasting ketones in the morning after the exercise tests were generally low (all ≤0.8 mmol/l), but were significantly higher for D20-P than D40 (0.27 ± 0.04 vs 0.16 ± 0.03 mmol/l,
PMC9988601
Short-acting insulin and carbohydrate intake
HYPERGLYCAEMIA, EVENT, HYPOGLYCAEMIA
The evening after the exercise test, three people (17%) in CON, one (6%) in D40 and one (6%) in D20-P injected additional short-acting insulin because of profound hyperglycaemia. During this evening, nine people (50%) in CON, five (28%) in D40 and two (11%) in D20-P ingested additional carbohydrates to prevent hypoglyc...
PMC9988601
Discussion
generalised, hypoglycaemia
EVENTS, TYPE 1 DIABETES, NOCTURNAL HYPOGLYCAEMIA, HYPOGLYCAEMIA
The main finding of this study is that adjustment of insulin degludec dosing after aerobic exercise performed in the afternoon had no effect on the incidence of subsequent nocturnal hypoglycaemia in people with type 1 diabetes. While next-day time below range was slightly reduced in the 40% dose reduction group, this d...
PMC9988601
Supplementary information
(PDF 450 kb)
PMC9988601
Acknowledgements
Diabetes
DIABETES
The authors thank all volunteers for their participation. The authors also express their gratitude to B. Kersten and E. Bakker from the Department of Physiology, Radboud University Medical Center, Nijmegen, the Netherlands, for assistance during the exercise tests and with analysing activity tracker data, respectively....
PMC9988601
Authors’ relationships and activities
BEdG is associate editor for
PMC9988601
Contribution statement
EJA, CJT and BEdG designed the study. LCAD recruited the participants, performed the experiments, collected the data, analysed the data and wrote the first version of the manuscript. LCAD, MA and LR performed the statistical analyses. All authors discussed the results and implications, commented on the manuscript at al...
PMC9988601
Funding
Nordisk
This study was conducted with an unrestricted grant from Novo Nordisk, Denmark. Novo Nordisk was not involved in the collection, analyses and interpretation of data, nor in writing the report and the decision to submit for publication.
PMC9988601
Data availability
The datasets generated during and/or analysed in the current study are available from the corresponding author upon reasonable request.
PMC9988601
References
PMC9988601
Subject terms
Mediolateral weight-shifting is an important aspect of postural control. As it is currently unknown whether a short training session of mediolateral weight-shifting in a virtual reality (VR) environment can improve weight-shifting, we investigated this question and also probed the impact of practice on brain activity. ...
PMC10638445
Introduction
Weight-shifting constitutes an important component of dynamic postural control, which refers to the ability to keep one’s bodyweight within the base of supportMost studies on learning-induced neural activation changes have focused on upper extremity tasksFunctional Near-Infrared Spectroscopy (fNIRS) is a mobile neuroim...
PMC10638445
Results
Some missing data were apparent due to recording problems (once due to the fNIRS-cap and once due to the wasp game). One participant in EXP was not willing to perform the DT condition, and one participant in CTR found the fNIRS system uncomfortable at retention.
PMC10638445
Participant characteristics
SD
Participants were recruited, trained and tested between January 4th and June 16th, 2021. Forty-three healthy older adults were initially recruited for participation, as three participants had to be excluded after signing the informed consent. Two did not meet the in/exclusion criteria (one had a MoCA score below 26 and...
PMC10638445
Behavioral results
PMC10638445
Training effects on weight-shifting performance in ST
Significant time by group interactions were revealed for all three outcomes (speed: F(
PMC10638445
Training effects on weight-shifting performance in DT
When adding the cognitive DT to the weight-shifting assessments, a comparable pattern of interaction effects was found (speed: F
PMC10638445
Training effects on functional limits of stability and overall balance
Figure Functional limits of stability (fLOS) for the (
PMC10638445
fNIRS results
PMC10638445
Training effects on cortical hemodynamics
Cortical hemodynamics during ST showed a significant interaction effect for the SMA left (F(fNIRS HbOValues are displayed as mean ± SD (μmol/L). Bold values indicate statistical significance and effect sizes of significant post-hoc tests. Note that only within-group time effects were explored post-hoc.
PMC10638445
Exploratory analyses
To determine which people responded best to training, correlation analyses were conducted and revealed that participants in EXP who had a better overall balance at baseline (higher MiniBEST score) also tended to have a larger ST speed improvement from pre-assessment to 24 h-retention (r = 0.456, p = 0.043, see Suppleme...
PMC10638445
Discussion
BLIND
This is the first study that investigated whether a single-session VR-based balance training led to changes in weight-shifting behavior and brain activity in older adults. Older adults were able to improve their weight-shifting capacity after the session during ST and DT test-conditions, the latter reflecting that the ...
PMC10638445
Materials and methods
PMC10638445
Participants
chronic musculoskeletal problems, balance impairments, cardiovascular or respiratory disease, diabetes
DIABETES, MAY, NEUROLOGICAL DISORDERS
In total, we recruited forty-three healthy older adults through our local GDPR-proof databases, of which forty were included in the actual study protocol. Participants had to be able to stand upright for a minimum of 5 min without using an aid and were excluded if they presented any medical problems that could influenc...
PMC10638445
Experimental procedure and tasks
PMC10638445
Procedure
This randomized controlled trial was pre-registered at clinicaltrials.gov (ID: NCT04594148, first registration: 20/10/2020, including full trial protocol) and consisted of two test sessions at the Movement and Analysis Laboratory Leuven (MALL). Healthy older adults were randomly allocated to either the training (EXP, n...
PMC10638445
Interventions
Mediolateral weight-shift training was performed via a VR wasp game (see Supplementary Fig. The 25-min training was divided into 10 blocks of 2.5 min with a 30 s rest period in between blocks. A longer break of 2 min was provided after five blocks with the opportunity to rest on a chair. Participants were instructed to...
PMC10638445
Weight-shifting assessment
Weight-shifting assessments were performed at pre, post and retention. For this purpose, the wasp game was executed in both single- (ST) and dual-task (DT) conditions. During DT, participants had to perform serial subtractions in threes, while hitting the wasps (see Supplementary Fig. 
PMC10638445
fNIRS assessment
BRAIN
Brain hemodynamics were captured with the continuous wave, single-phase NIRSport2 system (NIRx, Berlin, Germany), with LED wavelengths of 760 and 850 nm and a sampling frequency of 7.81 Hz, following consensus guidelines
PMC10638445
Cognitive assessment and other descriptors
sarcopenia
SARCOPENIA
After the experimental procedures on day 2, participants performed a descriptive test battery. We used the MoCA for assessment of cognitive ability. Other questionnaires included the Falls Efficacy Scale International (FES-I) to assess concern about falling, the sarcopenia questionnaire (SARC-F) and the Pittsburgh Slee...
PMC10638445
Data processing
PMC10638445
Weight-shifting data
Matlab 2018b (Mathworks, MA, USA) was used to process the CoM data as calculated in real time within the D-Flow software
PMC10638445
fNIRS data
CORTEX
fNIRS data were imported into Matlab (version 2018b, Mathworks, MA, USA) and analyzed using the NIRS toolbox (open access; Visually checking raw signals and resampling signals to 5 Hz. Converting raw signals into optical density using the Beer–Lambert law for which a partial path length correction factor of 0.1 was us...
PMC10638445
Statistical analysis
An a-priori sample size calculation (see clinicaltrials.gov, ID: NCT04594148) determined that we required 40 participants (20 per group). However, during data analyses, an error was found in that calculation, so an additional sensitivity power analysis was performed. From this, we determined that our sample of 40 is su...
PMC10638445
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-023-46645-4.
PMC10638445
Acknowledgements
A special word of thanks is direction towards Marie Bogaerts, Annelien Loverix, Hanne Vandenbossche and Ella Copermans for their crucial involvement during data collection. Above all, the authors are grateful for the enthusiastic contributions of all participants, without whom this study would not have been possible. T...
PMC10638445
Author contributions
RECRUITMENT
V.R. was responsible for the recruitment, data collection, data analysis and writing of the manuscript. N.D. contributed to the data and statistical analysis. F.H. helped with the data collection and data analysis. C.M. contributed to the sample size calculation and manuscript revisions. S.V. provided the infrastructur...
PMC10638445
Data availability
The datasets generated for this study will be made available upon reasonable request, which should be directed to the corresponding author.
PMC10638445
Competing interests
The authors declare no competing interests.
PMC10638445
References
PMC10638445
Objectives
DIE, EH
ENDOMETRIAL HYPERPLASIA
To compare the effectiveness of dienogest (DIE) and norethisterone acetate (NETA) regimens in the treatment of endometrial hyperplasia (EH) without atypia.
PMC10348941
Methods
DIE, irregular uterine bleeding
ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA
Participants were premenopausal women with irregular uterine bleeding, and endometrial hyperplasia without atypia on endometrial biopsy. Enrolled patients were randomly allocated into two groups: group I got DIE 2 mg/day (orally Visanne) for 14 days (10th to the 25th day of cycle) while group II received between the 16...
PMC10348941
Results
DIE
REGRESSION
The DIE group showed a higher resolution (32.7%) and regression (57.7%) than NETA group (31% & 37.9%, respectively) with significant regression (
PMC10348941
Conclusion
REGRESSION
If used as first-line treatment, Dienogest produces a better rate of regression and a lower incidence of hysterectomy than Norethisterone Acetate does when used in EH without atypia.
PMC10348941
Keywords
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).
PMC10348941
What does this study add to the clinical work
PMC10348941
Introduction
irregular uterine hemorrhage, endometrial cancer, endometriosis, hyperplasia, DIE, cancer, endometrial hyperplasia, amenorrhea, weight gain, acne
ENDOMETRIAL CANCER, ENDOMETRIOSIS, HYPERPLASIA, CELLULAR ATYPIA, ENDOMETRIAL HYPERPLASIA, CANCER, ENDOMETRIAL HYPERPLASIA, ACNE, CYTOLOGIC ATYPIA
Endometrial hyperplasia, which may lead to endometrial cancer or coexist with it, is characterized by an excessive growth of the endometrial glands [Although this ailment is often detected during the postmenopausal stage, it may occur at any age as long as the person is exposed to estrogen. The most significant risk fa...
PMC10348941
Patients and methods
PMC10348941
Study design and inclusion criteria
endometrial hyperplasia, abnormal endometrial thickness, abnormal uterine hemorrhage
ENDOMETRIAL HYPERPLASIA, ABNORMAL UTERINE HEMORRHAGE, ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA
A prospective controlled study of premenopausal women between the ages of 41 and 53 who were hospitalized to the Obstetrics and Gynecology Department at Zagazig University between January 2020 and October 2021 with abnormal uterine hemorrhage and persistent pelvic discomfort participated in an interventional prospectiv...
PMC10348941
Exclusion criteria
liver, kidney, heart, diabetes, AUB, breast cancers, hyperplasia
ABNORMAL UTERINE BLEEDING, BREAST CANCER, HYPERPLASIA, LEIOMYOMA, THROMBOEMBOLIC DISEASE
However, those with localized endometrial lesions like leiomyoma or atypical or complicated hyperplasia who have had hormone treatment within the last six months are at higher risk and other causes of abnormal uterine bleeding (AUB) like adnexal swellings and genital and breast cancers were excluded. Also, patients wit...
PMC10348941
Interventions
DIE, abnormal endometrial thickness
STERILE, PROLIFERATIVE, REGRESSION, PATHOLOGY, ATROPHIC
Enrolled patients were randomly allocated into two groups; group I got DIE 2 mg/day (orally Visanne; bayer pharma, Cairo, Egypt) for 14 days (10th to the 25th day of cycle) while Between the 16th and 25th day of the cycle, group II got norethisterone acetate (NETA) 15 mg/d (orally Primolut Nor; Hi Pharma, Cairo, Egypt)...
PMC10348941
Statistical analysis
SD
On an IBM compatible computer, the acquired data were tabulated and analyzed utilizing SPSS (statistical software for social research), version 25 (IBM, Armonk, NY, USA). Quantitative continues group represents by mean ± SD and compared between them by independent t test and paired t test while qualitative represents a...
PMC10348941
Discussion
Endometrial hyperplasia
ENDOMETRIAL HYPERPLASIA, UTERUS
Endometrial hyperplasia is a widespread condition. Particularly in Arab nations, the uterus is seen as a sign of women and femininity. Her psychological state will be greatly impacted by having her uterus removed. Therefore, every effort must be made to maintain the uterus as much as possible.
PMC10348941
Main findings
DIE
To the extent that we are aware, there is insufficient data regarding effect of DIE in EH without atypia and our study is a unique one to compare its effect versus NETA as a conventional treatment of EH.
PMC10348941
Strengths and limitations
The main limitation of research was the small size of study groups, and the factors strengthen the study, the prospective nature of study and use of inclusion and exclusion criteria with coding of the data collected for proper interpretation.
PMC10348941
Interpretation
irregular bleeding, mastalgia, DIE, cancer, nausea &vomiting
REGRESSION, CANCER
A fourth-generation progestin called DIE was employed in hormone replacement treatment and contraceptive pills [It is well known that progestins speed up the signaling pathways that prevent endometrial cells from undergoing cancer development [A research by Kodama et al. [Ozdegirmenci et al. [In the current study, we u...
PMC10348941
Acknowledgements
PATHOLOGY
Thank you to the pathology and gynecological team for their cooperation.
PMC10348941
Author contribution
EFG: study design, writing and share in gynecological work up of study. HMA: share in gynecological work up of study. HES: collect the study groups and share in writing of study. AMR: share in writing of study and share in gynecological work up of study.
PMC10348941
Funding
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). The research, writing, and/or publishing of this work were all done without any financial assistance from the authors.
PMC10348941
Data availability
Data available on reasonable request.
PMC10348941
Declarations
PMC10348941
Conflict of interest
No conflicts of interest.
PMC10348941
Ethical approval
Before enrolling in our trial, we obtained written informed permission from every participant, and they were all free to withdraw at any moment throughout follow-up. The Faculty of Medicine at Zagzig University in Egypt's Institutional Review Board and ethics committee gave their approval to the study's protocol.
PMC10348941
References
PMC10348941
Background
obesity
OBESITY
Mandatory calorie labelling in the out-of-home food sector was introduced in England in 2022, and menu pricing strategies that ensure cost is equivalent to portion size (proportional pricing) have been proposed as a policy to reduce obesity. Food delivery app-based platforms now contribute significantly to diet, and ev...
PMC10508026
Objective
This experimental study assessed the impact of calorie labelling and proportional pricing on item and meal size selection, calories ordered, and money spent when selecting food and drinks from three outlet types on a virtual delivery app.
PMC10508026
Methods
SHOP
UK adult participants (N = 1126, 49% female), stratified by gender and education level completed an online study where they ordered items from three branded food and beverage outlets (coffee shop, sandwich outlet, fast food outlet) using a virtual delivery app. Participants were presented food and beverage options with...
PMC10508026
Results
SHOP
Calorie labelling did not influence portion size selection for any outlets, but significantly reduced calories ordered from the coffee shop (-18.95kcals, 95% CI -33.07 to -4.84) and fast food outlet (-54.19kcals, 95% CI -86.04 to -22.33). Proportional pricing reduced the likelihood of choosing a larger beverage from th...
PMC10508026
Conclusions
Calorie labelling on food delivery platforms may effectively reduce calories ordered. Proportional pricing may be useful in prompting consumers to select smaller portion sizes, although further research in real-world settings will now be valuable.
PMC10508026
Supplementary Information
The online version contains supplementary material available at 10.1186/s12966-023-01513-2.
PMC10508026
Keywords
PMC10508026
Introduction
Globally, there has been an increase in the presence, and use of food delivery platforms [Food prepared outside the home, whether from fast food, takeaway, or full service restaurants is typically greater in energy than food prepared at home [In the UK, public health strategies to improve the nutritional quality of foo...
PMC10508026
Methods
PMC10508026
Study sample
RECRUITMENT
Participants (final N = 1126) were recruited through the online research platform Prolific [ Adapted consort flowchart of participant recruitment through to completion
PMC10508026
Design
RECRUITMENT
This study used a 2 × 2 between-subjects design. Upon recruitment, participants were randomly assigned to one of four experimental conditions: calorie labels and value pricing; calorie labels and proportional pricing; no calorie labels and value pricing; no calorie labels and proportional pricing. Participants were rec...
PMC10508026
Demographic and participant characteristic measures
Online questionnaires collected self-reported data on gender, age, ethnicity, height, weight, and SEP. The primary measure of SEP was the highest educational level achieved, for which there were six options (less than high school, high school completion, college or foundation degree, bachelor’s degree, master’s degree,...
PMC10508026
Food choice motives
After completing orders from all three food outlets (described below), participants were presented with subscales of the Food Choice Motives Questionnaire [
PMC10508026
Virtual delivery app
HAND PRESENTATION, SHOP
A virtual delivery app (Supplementary material II) was created using the program Inquisit 6, and modelled on a popular UK-based food delivery platform. Three large chain food outlets in the UK (a coffee shop, a sandwich shop, and a fast food outlet) were simulated as they each typically offer products at a larger size ...
PMC10508026
Other measures
After providing consent, participants were asked to guess the aim of the study. Guesses relating to kcals/calorie information on food choice or food price on food choice were coded as correctly guessed. Aim guessing was coded independently by two authors (AF, RM) and inconsistencies were resolved through discussion or ...
PMC10508026
Procedure
thirst
After providing consent, participants were randomly assigned to one of the four conditions. Baseline demographic data were collected, and participants completed items on how frequently food apps generally, and the three simulated food outlets in the study, were used by participants. Participants next completed hunger a...
PMC10508026
Analysis
We followed a pre-registered analysis strategy (osf.io/kaju5 [
PMC10508026
Primary analyses
REGRESSIONS
Primary outcomes for this study were size choice (medium or large), hypothetical kcals ordered, and hypothetical money spent from each outlet. For each outlet, binary logistic regressions were used to examine the association between calorie labelling condition (present/absent) and pricing condition (proportional/value)...
PMC10508026
Unplanned additional analyses
REGRESSION
Data from the three outlets were combined to examine any overall effects of calorie labelling condition and proportional pricing condition across the three outlet types. For size choice, participants were given a score of 0 to 3 according to the number of times they selected a larger portion size. A linear regression m...
PMC10508026
Secondary analyses
INTERACTIONS, SECONDARY
Interactions between participant characteristics (BMI, education, food choice motives, age, gender and ethnicity) and experimental conditions were investigated at a second step in each of the models outlined in the primary analyses. Results for secondary analyses were considered significant at p < .01 to account for mu...
PMC10508026
Sensitivity analyses
SENSITIVITY
Sensitivity analyses (Supplementary Material VI) revealed that results were largely the same whether subjective social status or equivalised household income were used in place of highest education level as a measure of SEP. Additional sensitivity analyses identified no differences in significance for primary findings ...
PMC10508026